EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All Resources2023 EKF Workshop - Logistical Challenges to Clinical Trial Management
Topics: EKF - 2023, Logistics, Supply Chain
Presentation
Members
Navigating Regulatory and QA Challenges in Clinical Supply Management
Topic: Regulatory
Executive Summary
Members
2023 EKF Workshop - What to Know & What to Avoid, to Experience the Greatest Success When Sourcing Comparators
Topics: EKF - 2023, Strategic Planning, Supply Chain
Presentation
Members
